Pharmaceutical

Hi.

Yes — there is a publicly stated fee‑refund policy for Dnyaan Prasad Global University (DPGU) — which includes its School of Pharmacy and Research (SPR).

According to the official refund / cancellation policy page of DPGU / its umbrella institute:

If a student withdraws or cancels admission before the start of the academic session / before the formally‑notified last date of admission, they are eligible for full refund of the collected fees — after deduction of a small administrative / processing charge (₹ 1,000).

If withdrawal happens less than 15 days before the last date of admission, then 90% of the fees will be refunded. 

There are defined refund tiers depending on when the withdrawal notice is received: even up to some days after the last date of admission (or after session begins), partial refunds may apply as per university's policy.

Hi.

Yes — there are scholarship / fee‑waiver schemes at Dnyaan Prasad Global University (DPGU)'s School of Pharmacy and Research (SPR) that could apply to students from economically weaker sections — but I did not find clear, public confirmation that there are dedicated “minority‑community scholarships” (i.e. for religious or linguistic minorities) explicitly listed among SPR's own scholarship categories. Here's what I found, and what remains uncertain:

• SPR lists several scholarship/fee‑waiver categories: merit‑based (“Chancellor's Scholarship”, “Bhagyavidya Scholarship”), “EWS / economically weaker section” scholarship, “Sports achiever” scholarships, gender-based waivers (girls), etc.

• The “EWS Scholarship” at SPR appears aimed at economically weaker‑section students (with limits on family income) — this could include students from underprivileged backgrounds irrespective of caste/community. 

• SPR makes reference to “scholarships / concessions … for economically weaker section candidates” among its financial‑aid/fee‑waiver schemes.

This certification is highly relevant and often a prerequisite for a career in biotechnology or Pharmaceutical companies. These industries are heavily regulated, and they rely on accurate, high-quality data to prove the safety and efficacy of their products to regulatory bodies like the FDA. 

A certification demonstrates that a candidate understands the complex data management lifecycle, from data collection to database lock, and is familiar with critical standards such as ICH-GCP and 21 CFR Part 11. It shows employers that you have the skills to handle sensitive clinical trial data with integrity and in compliance with global standards, making you a valuable asset.